AZ looks at Almac’s Flexyte platform for drug discovery
UK drug major AstraZeneca will evaluate Almac’s antibody and radiolabelling-free Flexyte kinase assay platform for drug discovery operations.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs